S.I. No. 69/1993 - Medical Preparations (Prescription and Control of Supply) Regulations, 1993
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
2 amending acts · 2017-05-05, S.I. No. 173/2017 - Misuse of Drugs Regulations 2017
| "g" | for gram, | "mcg" | for microgram, |
| "mg" | for milligram, | "ml" | for millilitre. |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Acarbose | B | ||
| Acebutolol Hydrochloride | B | ||
| Acecarbromal | B | ||
| Acepromazine Maleate | B | ||
| Acetanilide | B | ||
| Acetarsol | A | ||
| Acetazolamide | B | ||
| Acetazolamide Sodium | B | ||
| Acetohexamide | B | ||
| Acetophenazine Maleate | B | ||
| Acetrizoate Sodium | C | ||
| Acetrizoic Acid | C | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | |||
| Column 1 | Column 2 | Column 2 | Column 3 |
| Substance | Part in Schedule | Part in Schedule | Maximum Strength and Maximum Pack Size |
| Acetylcholine Chloride | B | B | 0.2 per cent (MS) |
| Acetylcysteine | A | A | |
| Acipimox | B | B | |
| Acitretin | A | A | |
| Aconite | B | B | 1.3 per cent (MS) |
| Acrosoxacin | A | A | |
| Actaplanin | A | A | |
| Actinomycin C | A | A | |
| Actinomycin D | A | A | |
| Acyclovir | A | A | 5.0 per cent (MS) 2.0g (MPS) |
| Ardrenaline | B | B | (1) 0.6 per cent (MS) |
| Adrenaline Acid Tartrate | B | B | (1) 1.0 per cent (MS) |
| Adrenaline Hydrochloride | B | B | (1) 0.6 per cent (MS) |
| Adrenocortical Extract | A | A | |
| Alclofenac | B | B | |
| Alclomethasone Dipropionate | A | A | |
| Alcuronium Chloride | A | A | |
| Aldosterone | A | A | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Alfacalcidol | B | ||
| Alfentanil Hydrochloride | A | ||
| Alfuzosin | B | ||
| Alfuzosin Hydrochloride | B | ||
| Allergen Extracts | B | ||
| Allopurinol | B | ||
| Allyloestrenol | A | ||
| Almitrine | B | ||
| Aloxiprim | B | ||
| Alphadolone Acetate | A | ||
| Alphaxalone | A | ||
| Alprazolam | A | ||
| Alprenolol | B | ||
| Alprenolol Hydrochloride | B | ||
| Alprostadil | A | ||
| Alseroxylon | B | ||
| Amantadine Hydrochloride | B | ||
| Ambenonium Chloride | A | ||
| Ambutonium Bromide | A | 5mg (MD) 20 mg (MDD) | |
| Amcinonide | B | ||
| Ametazole Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Amethocaine | A | Any use except local ophthalmic use | |
| Amethocaine Gentisate | A | Any use except local ophthalmic use | |
| Amethocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Amikacin Sulphate | A | ||
| Amiloride Hydrochloride | B | ||
| Aminocaproic Acid | B | ||
| Aminoglutethimide | B | ||
| Aminophylline | B | ||
| Aminopterin Sodium | A | ||
| Amiodarone Hydrochloride | B | ||
| Amiphenazole Hydrochloride | B | ||
| Amitriptyline | A | ||
| Amitriptyline Embonate | A | ||
| Amitriptyline Hydrochloride | A | ||
| Amlodipine Besylate | B | ||
| Amlodipine Maleate | B | ||
| Ammonium Bromide | B | ||
| Amodiaquine Hydrochloride | B | Prophylaxis of malaria | |
| Amoxapine | A | ||
| Amoxycillin | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Amoxycillin Trihydrate | A | ||
| Amphetamine Sulphate | A | ||
| Amphomycin Calcium | A | ||
| Amphotericin | A | ||
| Ampicillin Sodium | A | ||
| Ampicillin Trihydrate | A | ||
| Amrinone | B | ||
| Amsacrine | A | ||
| Amygdalin | A | ||
| Amyl Nitrite | A | ||
| Amylobarbitone | A | ||
| Amylobarbitone Sodium | A | ||
| Amylocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Ancrod | A | ||
| Androsterone | A | ||
| Angiotensin Amide | B | ||
| Anistreplase | A | ||
| Anterior Pituitary Extract | A | ||
| Antimony Barium Tartrate | B | ||
| Antimony Dimercaptosuccinate | B | ||
| Antimony Lithium Thiomalate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Antimony Pentasulphide | B | ||
| Antimony Potassium Tartrate | B | ||
| Antimony Sodium Tartrate | B | ||
| Antimony Sodium Thioglycollate | B | ||
| Antimony Sulphate | B | ||
| Antimony Trichloride | B | ||
| Antimony Trioxide | B | ||
| Antimony Trisulphide | B | ||
| Apiol | A | ||
| Apomorphine | B | ||
| Apomorphine Hydrochloride | B | ||
| Aprotinin | A | ||
| Arbaprostil | A | ||
| Arecoline Hydrobromide | B | ||
| Argipressin | A | ||
| Arsenic | A | ||
| Arsenic Triiodide | A | ||
| Arsenic Trioxide | A | ||
| Arsphenamine | A | ||
| Aspirin | B | (1) Internal: any use (except for children under 12 years of age) (2) External | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Astemizole | B | 10mg (MS) 10 (MPS) | |
| Atenolol | B | ||
| Atracurium Besylate | A | ||
| Atropine | B | (1) Internal: (a) by inhaler (b) otherwise than by inhaler | |
| (2) External (except local ophthalmic use) | |||
| Atropine Methobromide | B | (1) Internal: (a) by inhaler (b) otherwise than by inhaler | |
| (2) External (except local ophthalmic use) | |||
| Atropine Methonitrate | B | Internal: (a) by inhaler (b) otherwise than by inhaler | |
| Atropine Oxide Hydrochloride | B | (1) Internal: (a) by inhaler (b) otherwise than by inhaler | |
| (2) External (except local ophthalmic use) | |||
| Atropine Sulphate | B | (1) Internal: (a) by inhaler (b) otherwise than by inhaler | |
| (2) External (except local ophthalmic use) | |||
| Auranofin | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Azapropazone | B | ||
| Azathioprine | A | ||
| Azathioprine Sodium | A | ||
| Azidocillin Potassium | A | ||
| Azitromycin | A | ||
| Azlocillin Sodium | A | ||
| Aztreonam | A | ||
| Bacampicillin Hydrochloride | A | ||
| Bacitracin | A | ||
| Bacitracin Methylene Disalicylate | A | ||
| Bacitracin Zinc | A | ||
| Baclofen | B | ||
| Barbexaclone | A | ||
| Barbitone | A | ||
| Barbitone Sodium | A | ||
| Barium Carbonate | B | ||
| Barium Chloride | B | ||
| Barium Sulphate | C | ||
| Barium Sulphide | B | ||
| Beclamide | B | ||
| Beclomethasone | A | ||
| Beclomethasone Dipropionate | A | ||
| Belladonna Herb | B | (1) Internal | |
| (2) External | |||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Belladonna Root | B | (1) Internal | |
| (2) External | |||
| Bemegride | B | ||
| Bemegride Sodium | B | ||
| Benapryzine Hydrochloride | B | ||
| Bendrofluazide | B | ||
| Benethamine Penicillin | A | ||
| Benorylate | B | ||
| Benoxaprofen | B | ||
| Benperidol | A | ||
| Benserazide Hydrochloride | B | ||
| Bentiromide | A | ||
| Benzathine Penicillin | A | ||
| Benzbromarone | B | ||
| Benzhexol Hydrochloride | B | ||
| Benzilonium Bromide | B | ||
| Benzocaine | A | Any use except local ophthalmic use | |
| Benzoctamine Hydrochloride | B | ||
| Benzquinamide | B | ||
| Benzquinamide Hydrochloride | B | ||
| Benzthiazide | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Benztropine Mesylate | B | ||
| Benzydamine Hydrochloride | B | 3.0 per cent (MS) | External |
| Benzylpenicillin Calcium | A | ||
| Benzylpenicillin Potassium | A | ||
| Benzylpenicillin Sodium | A | ||
| Bepridil Hydrochloride | B | ||
| Betahistine Hydrochloride | B | ||
| Betamethasone | A | ||
| Betamethasone Adamantoate | A | ||
| Betamethasone Benzoate | A | ||
| Betamethasone Dipropionate | A | ||
| Betamethasone Sodium Phosphate | A | ||
| Betamethasone Valerate | A | ||
| Betaxolol Hydrochloride | B | ||
| Bethanechol Chloride | B | ||
| Bethanidine Sulphate | B | ||
| Bezafibrate | B | ||
| Bifonazole | B | ||
| Biperiden Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Biperiden Lactate | B | ||
| Bismuth Glycollylarsanilate | A | ||
| Bisprolol Fumarate | B | ||
| Bleomycin | A | ||
| Bleomycin Sulphate | A | ||
| Boldenone | A | ||
| Boldenone Undecanoate | A | ||
| Bornaprine Hydrochloride | B | ||
| Bretylium Tosylate | B | ||
| Bromazepam | A | ||
| Bromhexine Hydrochloride | B | Internal | |
| Bromocriptine Mesylate | B | ||
| Bromvaletone | B | ||
| Broom (Cytisus Scoparium Species) | A | ||
| Brotizolam | A | ||
| Budesonide | A | ||
| Bufexamac | B | 5.0 per cent (MS) | External |
| Buflomedil Hydrochloride | B | ||
| Bufuralol Hydrochloride | B | ||
| Bumetanide | B | ||
| Bunolol Hydrochloride | B | ||
| Buphenine Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Bupivacaine | A | Any use except local ophthalmic use | |
| Bupivacaine Hydrochloride | A | Any use except local ophthalmic use | |
| Buprenorphine | A | ||
| Buprenorphine Hydrochloride | A | ||
| Buserelin | A | ||
| Buserelin Acetate | A | ||
| Buspirone Hydrochloride | A | ||
| Busulphan | A | ||
| Butacaine Sulphate | A | Any use except local ophthalmic use | |
| Butobarbitone | A | ||
| Butobarbitone Sodium | A | ||
| Butorphanol Tartrate | A | ||
| Butriptyline Hydrochloride | A | ||
| Butyl Nitrite | A | ||
| Calcifediol | B | ||
| Calcipotriol | A | ||
| Calcitonin | B | ||
| Calcitriol | B | ||
| Calcium Benzamidosalicylate | B | ||
| Calcium Bromide | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Calcium Bromidolactobionate | B | ||
| Calcium Carbimide | B | ||
| Camazepam | A | ||
| Candicidin | A | ||
| Canrenoate Potassium | A | ||
| Canrenoic Acid | A | ||
| Cantharidin | B | 0.01 per cent (MS) | External |
| Canthaxanthin | B | ||
| Capreomycin Sulphate | A | ||
| Captopril | B | ||
| Carbachol | B | ||
| Carbamazepine | B | ||
| Carbasalate Calcium | B | (1) Internal: Any use (except for children under 12 years of age) | |
| Carbenicillin Sodium | A | ||
| Carbenoxolone Sodium | B | (1) Pellet | |
| (2) 2.0 per cent (MS) | (2) Gel | ||
| Carbidopa | B | ||
| Carbimazole | B | ||
| Carbocisteine | B | Internal | |
| Carbon Tetrachloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Carboplatin | A | ||
| Carboprost Tromethamol | A | ||
| Carbromal | B | ||
| Carbuterol Hydrochloride | B | ||
| Carfecillin Sodium | A | ||
| Carindacillin Sodium | A | ||
| Carisoprodol | B | ||
| Carmustine | A | ||
| Carperidine | A | ||
| Carteolol | B | ||
| Carteolol Hydrochloride | B | ||
| Cefaclor | A | ||
| Cefadroxil | A | ||
| Cefapirin Sodium | A | ||
| Cefazedone Sodium | A | ||
| Cefixime | A | ||
| Cefodizime | A | ||
| Cefonicid Sodium | A | ||
| Cefoperazone Sodium | A | ||
| Cefotaxime Sodium | A | ||
| Cefotiam Hydrochloride | A | ||
| Cefoxitin Sodium | A | ||
| Cefpodoxime | A | ||
| Cefpodoxime Proxetil | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Cefsulodin Sodium | A | ||
| Ceftazidime | A | ||
| Ceftizoxime Sodium | A | ||
| Ceftriaxone Sodium | A | ||
| Cefuroxime Axetil | A | ||
| Cefuroxime Pivoxetil | A | ||
| Cefuroxime Sodium | A | ||
| Celiprolol Hydrochloride | B | ||
| Cephalexin | A | ||
| Cephalexin Sodium | A | ||
| Cephaloridine | A | ||
| Cephalothin Sodium | A | ||
| Cephamandole Nafate | A | ||
| Cephazolin Sodium | A | ||
| Cephradine | A | ||
| Cerium Oxalate | B | ||
| Ceruletide | A | ||
| Ceruletide Diethylamine | A | ||
| Cetirizine | B | 10 mg (MS) 10 (MPS) | |
| Chenodeoxycholic Acid | B | ||
| Chloral Hydrate | B | External | |
| Chlorambucil | A | ||
| Chloramphenicol | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Chloramphenicol Cinnamate | A | ||
| Chloramphenicol Palmitate | A | ||
| Chloramphenicol Sodium Succinate | A | ||
| Chlordiazepoxide | A | ||
| Chlordiazepoxide Hydrochloride | A | ||
| Chlorhexadol | B | ||
| Chlormadinone Acetate | A | ||
| Chlormerodrin | B | ||
| Chlormethiazole | A | ||
| Chlormethiazole Edisylate | A | ||
| Chlormezanone | B | ||
| Chloroform | B | (1) 5.0 per cent (MS) | (1) Internal (2) External |
| Chloroquine Phosphate | B | Prophylaxis of malaria | |
| Chloroquine Sulphate | B | Prophylaxis of malaria | |
| Chlorothiazide | B | ||
| Chlorotrianisene | A | ||
| Chlorphenoxamine Hydrochloride | B | External | |
| Chlorpromazine | B | ||
| Chlorpromazine Embonate | B | ||
| Chlorpromazine Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Chlorpropamide | B | ||
| Chlorprothixene | B | ||
| Chlorprothixene Hydrochloride | B | ||
| Chlortetracycline | A | ||
| Chlortetracycline Calcium | A | ||
| Chlortetracycline Hydrochloride | A | ||
| Chlorthalidone | B | ||
| Chlorzoxazone | B | ||
| Cholecalciferol | B | (1) Internal | |
| (2) External | |||
| Cholestyramine | B | ||
| Choline Magnesium Trisalicylate | B | ||
| Ciclacillin | A | ||
| Ciclobendazole | B | ||
| Ciclopirox | B | External (except vaginal use) | |
| Cilazapril | B | ||
| Cimetidine | B | ||
| Cimetidine Hydrochloride | B | ||
| Cinchocaine | B | 3.0 per cent (MS) | Any use except local ophthalmic use |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Cinchocaine Hydrochloride | B | Equivalent of 3.0 per cent of Cinchocaine (MS) | Any use except local ophthalmic use |
| Cinchophen | B | ||
| Cinnarizine | B | 15 (MPS) | |
| Cinoxacin | A | ||
| Ciprofibrate | B | ||
| Ciprofloxacin | A | ||
| Ciprofloxacin Hydrochloride | A | ||
| Ciprofloxacin Lactate | A | ||
| Cisapride | B | ||
| Cisplatin | A | ||
| Clarithromycin | A | ||
| Clavulanate Potassium | A | ||
| Clavulanic Acid | A | ||
| Clenbuterol Hydrochloride | B | ||
| Clidinium Bromide | B | ||
| Clindamycin | A | ||
| Clindamycin Hydrochloride | A | ||
| Clindamycin Palmitate Hydrochloride | A | ||
| Clindamycin Phosphate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Clioquinol | B | (1) 35mg | (1) Treatment of mouth ulcers (2) External (other than treatment of mouth ulcers) |
| Clobazam | A | ||
| Clobetasol Propionate | A | ||
| Clobetasone Butyrate | A | ||
| Clodronate Sodium | B | ||
| Clofazimine | B | ||
| Clofibrate | B | ||
| Clomacran Phosphate | B | ||
| Clomiphene Citrate | A | ||
| Clomipramine | A | ||
| Clomipramine Hydrochloride | A | ||
| Clomocycline | A | ||
| Clomocycline Sodium | A | ||
| Clonazepam | A | ||
| Clonidine | B | ||
| Clonidine Hydrochloride | B | ||
| Clopamide | B | ||
| Clopenthixol Decanoate | B | ||
| Clopenthixol Hydrochloride | B | ||
| Clorazpate Potassium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Clorexolone | B | ||
| Clostebol Acetate | A | ||
| Clotiazepam | A | ||
| Clotrimazole | B | External: (1) Cream (2) Powder (3) Solution | |
| Clovoxamine | A | ||
| Cloxacillin Benzathine | A | ||
| Cloxacillin Sodium | A | ||
| Cloxazolam | A | ||
| Clozapine | A | ||
| Co-dergocrine Mesylate | B | ||
| Co-tetroxazine | A | ||
| Co-trimoxazole | A | ||
| Cocaine | A | ||
| Cocaine Hydrochloride | A | ||
| Cocculus Indicus | A | ||
| Codeine Phosphate | A | Equivalent of 1.5 per cent of Codeine (MS) | |
| Colaspase | A | ||
| Colchicine | A | ||
| Colestipol Hydrochloride | B | ||
| Colfosceril Palmitate | A | ||
| Colistin Sulphate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Colistin Sulphomethate | A | ||
| Colistin Sulphomethate Sodium | A | ||
| Comfrey (Symphytum Species) | A | External | |
| Coniine | B | ||
| Conium Leaf | B | 7.0 per cent (MS) | External |
| Corticotrophin | A | ||
| Cortisone | A | ||
| Cortisone Acetate | A | ||
| Cromoglycate Sodium | B | (1) Administration through the nose (2) Eye Drops | |
| Cropropamide | B | ||
| Crotethamide | B | ||
| Croton Oil | A | ||
| Croton Seed | A | ||
| Curare | A | ||
| α-Cyanobenzylp-ß-D-glucopyranosiduronic Acid | B | 0.1 per cent (MS) | |
| α-Cyanobenzyl-6—O-P ß-D-glucopyranosyl -ß-D-glucopyranoside | B | 0.1 per cent (MS) | |
| Cyanocobalamin | B | 25mcg (MS) | |
| Cyanocolbalamin | B | 25mcg (MS) | |
| Cyclandelate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Cyclobarbitone | A | ||
| Cyclobarbitone Calcium | A | ||
| Cyclofenil | A | ||
| Cyclopenthiazide | B | ||
| Cyclopentolate Hydrochloride | B | ||
| Cyclophosphamide | A | ||
| Cycloserine | A | ||
| Cyclosporin | B | ||
| Cyclothiazide | B | ||
| Cyproterone Acetate | A | ||
| Cytarabine | A | ||
| Cytarabine Hydrochloride | A | ||
| Dacarbazine | A | ||
| Danazol | B | ||
| Danthron | B | ||
| Dantrolene Sodium | B | ||
| Dapsone | A | ||
| Dapsone Ethane Ortho Sulphonate | A | ||
| Daunorubicin Hydrochloride | A | ||
| Deanol Bitartrate | B | ||
| Debrisoquine Sulphate | B | ||
| Deflazacort | A | ||
| Delorazepam | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Demecarium Bromide | B | ||
| Demeclocycline | A | ||
| Demeclocycline Calcium | A | ||
| Demeclocycline Hydrochloride | A | ||
| Deoxycortone Acetate | A | ||
| Deoxycortone Pivalate | A | ||
| Deptropine Citrate | B | ||
| Dequalinium Chloride | B | (1) 0.25mg (MS) | (1) Internal: throat lozenges or throat pastilles |
| (2) 1.0 per cent (MS) | (2) External: paint | ||
| Deserpidine | B | ||
| Desferrioxamine Mesylate | B | ||
| Desfluorotriamcinolone | A | ||
| Desipramine Hydrochloride | A | ||
| Deslanoside | B | ||
| Desmopressin | B | ||
| Desogestrel | A | ||
| Desonide | A | ||
| Desoxymethasone | A | ||
| Dexamethasone | A | ||
| Dexamethasone Acetate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Dexamethasone Isonicotinate | A | ||
| Dexamethasone Phenylpropionate | A | ||
| Dexamethasone Pivalate | A | ||
| Dexamethasone Sodium m- Sulphobenzoate | A | ||
| Dexamethasone Sodium Phosphate | A | ||
| Dexamethasone Troxundate | A | ||
| Dexamphetamine Sulphate | A | ||
| Dexfenfluramine Hydrochloride | A | ||
| Dextromethorphan Hydrobromide | B | Internal | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Dextromethorphan Resinate | B | Internal | |
| Dextromoramide Hydrochloride | A | ||
| Dextromoramide Tartrate | A | ||
| Dextropropoxyphene Hydrochloride | B | ||
| Dextropropoxyphene Napsylate | B | ||
| Dextrothyroxine Sodium | B | ||
| Diatrizoate Meglumine | C | ||
| Diatrizoate Sodium | C | ||
| Diatrizoic Acid | C | ||
| Diazepam | A | ||
| Diazoxide | A | ||
| Dibenzepin Hydrochloride | A | ||
| Dichloralphenazone | B | ||
| Dichlorphenamide | B | ||
| Diclofenac Diethylammonium | B | Equivalent of 1.0 per cent of diclofenac (MS) 30.0g (MPS) | External: Rheumatic and muscular pain |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Diclofenac Sodium | B | ||
| Dicylomine Hydrochloride | B | Internal (other than liquid preparations intended for infants) | |
| Dienoestrol | A | ||
| Diethanolamine Fusidate | A | ||
| Diethylcarbamazine | B | ||
| Diethylcarbamazine Citrate | B | ||
| Diethylpropion Hydrochloride | A | ||
| Difenoxin Hydrochloride | A | ||
| Diflucortolone Valerate | A | ||
| Diflunisal | B | ||
| Digitalin | B | ||
| Digitalis Leaf | B | ||
| Digitalis Prepared | B | ||
| Digitoxin | B | ||
| Digoxin | B | ||
| Dihydralazine Sulphate | B | ||
| Dihydrocodeine Tartrate | A | Equivalent of 1.5 per cent of Dihydrocodeine (MS) | |
| Dihydroergotamine Mesylate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Dihydrostreptomycin | A | ||
| Dihydrostreptomycin Sulphate | A | ||
| Dihydrotachysterol | B | 0.075mg (MDD) | |
| Diiodohydroxy quinoline | B | ||
| Diloxanide Furoate | B | ||
| Diltiazem Hydrochloride | A | ||
| Diltiazem Hydrochloride | B | ||
| Dimercaprol | B | ||
| Dimethisoquin Hydrochloride | B | Any use except local ophthalmic use | |
| Dimethisterone | A | ||
| Dimethothiazine Mesylate | B | ||
| Dimethyl Sulphoxide | A | ||
| Dimethyltubocurarine Bromide | A | ||
| Dimethyltubocurarine Chloride | A | ||
| Dimethyltubocurarine Iodide | A | ||
| Dinoprost | C | ||
| Dinoprost Trometamol | C | ||
| Dinoprostone | C | ||
| Diodone | C | ||
| Diphenoxylate Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparation from prescription control | Circumstances excluding medical preparation from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Dipipanone Hydrochloride | A | ||
| Dipivefrine | A | ||
| Dipivefrine Hydrochloride | A | ||
| Dipyridamole | B | ||
| Disopyramide | B | ||
| Disopyramide Phosphate | B | ||
| Distigmine Bromide | B | ||
| Disulfiram | B | ||
| Dithranol | B | 0.1 per cent (MS) | |
| Dithranol Triacetate | B | 0.1 per cent (MS) | |
| Dobutamine Hydrochloride | B | ||
| Domperidone | B | Oral solid unit dosage forms | |
| Dopamine Hydrochloride | A | ||
| Dopexamine Hydrochloride | B | ||
| Dothiepin | A | ||
| Dothiepin Hydrochloride | A | ||
| Doxapram Hydrochloride | A | ||
| Doxazosin Mesylate | A | ||
| Doxepin Hydrochloride | A | ||
| Doxorubicin | A | ||
| Doxycycline | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparation from prescription control | Circumstances excluding medical preparation from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Docycycline Calcium Chelate | A | ||
| Doxycycline Hydrochloride | A | ||
| Doxylamine Succinate | B | ||
| Droperidol | A | ||
| Drostanolone | A | ||
| Drostanolone Propionate | A | ||
| Dydrogesterone | A | ||
| Dyflos | B | ||
| Econazole | B | External (except vaginal use) | |
| Econazole Nitrate | B | External (except vaginal use) | |
| Ecothiopate Iodide | A | ||
| Edrophonium Chloride | A | ||
| Embutramide | A | ||
| Emepronium Bromide | B | ||
| Emetine | B | 1.0 per cent (MS) | |
| Emetine Bismuth Iodide | B | ||
| Emetine Hydrochloride | B | Equivalent of 1.0 per cent of Emetine (MS) | |
| Enalpril | B | ||
| Encainide | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparation from prescription control | Circumstances excluding medical preparation from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Endralazine | B | ||
| Enoxacin | A | ||
| Enoximone | A | ||
| Enprostil | A | ||
| Ephedrine | B | External (except local ophthalmic use) | |
| Ephedrine Hydrochloride | B | External (except local ophthalmic use) | |
| Ephedrine Sulphate | B | External (except local ophthalmic use) | |
| Epicillin | A | ||
| Epithiazide | B | ||
| Epoetin Alfa | A | ||
| Epoetin Beta | A | ||
| Epoprostenol Sodium | A | ||
| Ergocalciferol | B | ||
| Ergometrine Maleate | B | ||
| Ergometrine Tartrate | B | ||
| Ergot, Prepared | B | ||
| Ergotamine Tartrate | B | ||
| Erythromycin | A | ||
| Erythromycin Estolate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparation from prescription control | Circumstances excluding medical preparation from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Erythromycin Ethyl Carbonate | A | ||
| Erythromycin Ethyl Succinate | A | ||
| Erythromycin Lactobionate | A | ||
| Erythromycin Phosphate | A | ||
| Erythromycin Stearate | A | ||
| Erythromycin Thiocyanate | A | ||
| Esmolol Hydrochloride | B | ||
| Estazolam | A | ||
| Estramustine Phosphate | A | ||
| Etafedrine Hydrochloride | B | ||
| Ethacrynate Sodium | B | ||
| Ethacrynic Acid | B | ||
| Ethambutol Hydrochloride | B | ||
| Ethamivan | B | ||
| Ethamsylate | B | ||
| Ethchlorvynol | B | ||
| Ethebenecid | B | ||
| Ethiazide | B | ||
| Ethinyl Androstenediol | A | ||
| Ethinyloestradiol | A | ||
| Ethionamide | B | ||
| Ethisterone | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Ethoglucid | A | ||
| Ethoheptazine Citrate | A | ||
| Ethopropazine Hydrochloride | A | ||
| Ethosuximide | B | ||
| Ethotoin | B | ||
| Ethyl Biscoumacetate | B | ||
| Ethyl Loflazepate | A | ||
| Ethyl Moniodostearate | C | ||
| Ethylmorphine Hydrochloride | A | Equivalent of 0.2 per cent of Ethylmorphine(MS) | |
| Ethyloestrenol | A | ||
| Ethynodiol Diacetate | A | ||
| Etidronate Disodium | B | ||
| Etifoxine | A | ||
| Etodolac | B | ||
| Etofenamate | B | ||
| Etomidate | A | ||
| Etoposide | A | ||
| Etorphine Hydrochloride | A | ||
| Etretinate | A | ||
| Famotidine | B | ||
| Fazadinium Bromide | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparation from prescription control | Circumstances excluding medical preparation from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Felbinac | B | 3.17 per cent (MS) 30.0g (MPS) | External: Rheumatic and muscular pain |
| Felodipine | A | ||
| Felypressin | A | ||
| Fenbufen | B | ||
| Fencamfamin Hydrochloride | A | ||
| Fenclofenac | B | ||
| Fenfluramine Hydrochloride | A | ||
| Fenofibrate | B | ||
| Fenoprofen | B | ||
| Fenoprofen Calcium | B | ||
| Fenoterol Hydrobromide | B | ||
| Fentanyl Citrate | A | ||
| Feprazone | B | ||
| Ferrous Arsenate | B | ||
| Filgrastim | A | ||
| Finasteride | A | ||
| Flavoxate Hydrochloride | B | ||
| Flecainide Acetate | B | ||
| Floctafenine | B | ||
| Fluanisone | A | ||
| Flubendazole | B | ||
| Fluclorolone Acetonide | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Flucloxacillin Sodium | A | ||
| Fluconazole | B | ||
| Flucytosine | A | ||
| Fludiazepam | A | ||
| Fludrocortisone Acetate | A | ||
| Flufenamic Acid | B | ||
| Flumazenil | A | ||
| Flumethasone | A | ||
| Flumethasone Pivalate | A | ||
| Flunarizine Hydrochloride | B | ||
| Flunisolide | A | ||
| Flunitrazepam | A | ||
| Fluocinolone Acetonide | A | ||
| Fluocinonide | A | ||
| Fluocortin Butyl | A | ||
| Fluocortolone | A | ||
| Fluocortolone Hexanoate | A | ||
| Fluocortolone Pivalate | A | ||
| Fluorescein Dilaurate | A | ||
| Fluorescein Sodium | A | ||
| Fluorometholone | A | ||
| Fluorometholone Acetate | A | ||
| Fluorouracil | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Fluorouracil Trometamol | A | ||
| Fluoxetine | A | ||
| Fluoxetine Hydrochloride | A | ||
| Fluoxymesterone | A | ||
| Flupenthixol Decanoate | B | ||
| Flupenthixol Hydrochloride | B | ||
| Fluperolone Acetate | A | ||
| Fluphenazine Decanoate | B | ||
| Fluphenazine Enanthate | B | ||
| Fluphenazine Hydrochloride | B | ||
| Fluprednidene Acetate | A | ||
| Fluprednisolone | A | ||
| Fluprostenol Sodium | A | ||
| Flurandrenolone | A | ||
| Flurazepam Hydrochloride | A | ||
| Flurazepam Monohydrochloride | A | ||
| Flurbiprofen | B | ||
| Fluspirilene | A | ||
| Flutamide | A | ||
| Fluticasone Propionate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparation from prescription control | Circumstances excluding medical preparation from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Fluvoxamine Maleate | A | ||
| Folic Acid | B | ||
| Folinate Calcium | B | ||
| Formocortal | A | ||
| Foscarnet Sodium | A | ||
| Fosfestrol Sodium | A | ||
| Fosinopril | B | ||
| Fosinopril Sodium | B | ||
| Framycetin Sulphate | A | ||
| Frusemide | B | ||
| Furazolidone | B | ||
| Fusafungine | A | ||
| Fusidic Acid | A | ||
| Gadopentetate Meglumine | C | ||
| Gadopentetic Acid | C | ||
| Gallamine Triethiodide | A | ||
| Ganciclovir | A | ||
| Ganciclovir Sodium | A | ||
| Gelsemine | B | 0.1 per cent (MS) | |
| Gelsemium | B | ||
| Gemeprost | C | ||
| Gemfibrozil | B | ||
| Gentamicin | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Gentamicin Sulphate | A | ||
| Gestodene | A | ||
| Gestrinone | A | ||
| Gestronol | A | ||
| Gestronol Hexanoate | A | ||
| Ginkgo biloba | B | ||
| Glibenclamide | B | ||
| Glibornuride | B | ||
| Gliclazide | B | ||
| Glipizide | B | ||
| Gliquidone | B | ||
| Glisoxepide | B | ||
| Glucagon | B | ||
| Glutethimide | A | ||
| Glyceryl Trinitrate | B | ||
| Glycopyrronium Bromide | B | ||
| Glymidine | B | ||
| Gonadorelin | A | ||
| Gonadotrophin | A | ||
| Gonadotrophin Chortonic | A | ||
| Gonadotrophin Serum | A | ||
| Goserelin Acetate | A | ||
| Gramicidin | A | 0.2 per cent (MS) | External |
| Granisetron | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Granisetron Hydrochloride | A | ||
| Griseofulvin | A | ||
| Growth Hormone | A | ||
| Guanacline Sulphate | B | ||
| Guanethidine Monosulphate | B | ||
| Guanfacine Hydrochloride | B | ||
| Guanoclor Sulphate | B | ||
| Guanoxan Sulphate | B | ||
| Halazepam | A | ||
| Halcinonide | A | ||
| Haloperidol | A | ||
| Haloperidol Decanoate | A | ||
| Haloxazolam | A | ||
| Harmine | A | ||
| Heparin | A | External | |
| Heparin Calcium | A | External | |
| Heparin Sodium | A | External | |
| Heptabarbitone | A | ||
| Hexachlorophane | B | (a) 2.0 per cent (MS) | External: (a) soaps |
| (b) 0.1 per cent (MS) | (b) aerosols | ||
| (c) 0.75 per cent (MS) | (c) preparations other than soaps and aerosols | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Hexamethonium Bromide | A | ||
| Hexamethonium Iodide | A | ||
| Hexamethonium Tartrate | A | ||
| Hexamine Phenylcinchoninate | B | ||
| Hexobarbitone | A | ||
| Hexobarbitone Sodium | A | ||
| Hexoestrol | A | ||
| Hexoestrol Dipropionate | A | ||
| L-Histidine Hydrochloride | B | ||
| Homatropine | B | (1) Internal | |
| (2) External (except local ophthalmic use) | |||
| Homatropine Hydrobromide | B | ||
| Homatropine Methylbromide | B | ||
| Hydralazine Hydrochloride | B | ||
| Hydrargaphen | B | Local application to skin | |
| Hydrobromic Acid | B | ||
| Hydrochlorothiazide | B | ||
| Hydrocodone Resinate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Hydrocodone Tartrate | A | ||
| Hydrocortisone | A | 1.0 per cent (MS) 15.0g (MPS) | External: Contact dermatitis, irritant dermatitis and insect bite reactions. |
| Hydrocortisone Acetate | A | 1.0 per cent (MS) 15.0g (MPS) | External: Contact dermatitis, irritant dermatitis and insect bite reactions. |
| Hydrocortisone Butyrate | A | ||
| Hydrocortisone Caprylate | A | ||
| Hydrocortisone Hydrogen Succinate | A | ||
| Hydrocortisone Sodium Phosphate | A | ||
| Hydrocortisone Sodium Succinate | A | ||
| Hydroflumethiazide | B | ||
| Hydromorphone Hydrochloride | A | ||
| Hydroxocobalamin | B | 25mcg (MS) | |
| Hydroxychloroquine Sulphate | B | Prophylaxis of malaria | |
| Hydroxyprogesterone | A | ||
| Hydroxyprogesterone Enanthate | A | ||
| Hydroxyprogesterone Hexanoate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Hydroxyurea | A | ||
| Hydroxyzine Embonate | B | ||
| Hydroxyzine Hydrochloride | B | ||
| Hyoscine | B | (1) 0.15 per cent (MS) | (1) Internal |
| (2) External (except local ophthalmic use) | |||
| Hyoscine Butylbromide | B | (1) Internal: (a) By inhaler (b) Otherwise than by inhaler | |
| (2) External | |||
| Hyoscine Hydrobromide | B | (1) Internal: (a) By inhaler (b) Otherwise than by inhaler | |
| (2) External (except local ophthalmic use) | |||
| Hyoscine Methobromide | B | (1) Internal: (a) By inhaler (b) Otherwise than by inhaler | |
| (2) External | |||
| Hyoscine Methonitrate | B | (1) Internal: (a) By inhaler (b) Otherwise than by inhaler | |
| (2) External | |||
| Hyoscyamine | B | (1) Internal: (a) By inhaler (b) Otherwise than by inhaler | |
| (2) External | |||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| (3) Preparations for the relief of asthma in the form of cigarettes, smoking mixtures or fumigants which contain Hyoscyamine as an alkaloid of Stramonium | |||
| Hyoscyamine | B | (1) Internal: | |
| Hydrobromide | (a) By inhaler (b) Otherwise than by inhaler | ||
| (2)External | |||
| Hyoscyamine Sulphate | B | (1) Internal: (a) By inhaler (b) Otherwise than by inhaler | |
| (2) External | |||
| (1) Internal: | |||
| Ibuprofen | B | Rheumatic and muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | |
| (2)5.0 per cent (MS) 30.0g (MPS) | (2) External: Rheumatic and muscular pain | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substances | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Idarubicin Hydrochloride | A | ||
| Idoxuridine | A | 0.1 per cent (MS) | External (except local ophthalmic use): Cold sores |
| Ifosfamide | A | ||
| Ignatius Bean | B | ||
| Imipramine | A | ||
| Imipramine Hydrochloride | A | ||
| Imipramine Resinate | A | ||
| Impromidine Hydrochloride | A | ||
| Indapamide Hemihydrate | B | ||
| Indomethacin | B | ||
| Indoprofen | B | ||
| Indoramin Hydrochloride | B | ||
| Inosine Pranobex | A | ||
| Interferon Alfa | A | ||
| Interferon Beta | A | ||
| Interferon Gamma | A | ||
| Iobenamic Acid | C | ||
| Iocarmate Meglumine | C | ||
| Iocarmic Acid | C | ||
| Iodamide | C | ||
| Iodamide Meglumine | C | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Iodamide Sodium | C | ||
| Iodipamide | C | ||
| Iodipamide Meglumine | C | ||
| Iodised Oil | C | ||
| Iodohippurate Sodium | C | ||
| Iodoxamate Meglumine | C | ||
| Iodoxamic Acid | C | ||
| Ioglicate Meglumine | C | ||
| Ioglicic Acid | C | ||
| Ioglycamate Meglumine | C | ||
| Ioglycamate Sodium | C | ||
| Ioglycamic Acid | C | ||
| Iohexol | C | ||
| Iopamidol | C | ||
| Iopanoic Acid | C | ||
| Iophendylate | C | ||
| Iopromide | C | ||
| Iotasul | C | ||
| Iothalamate Meglumine | C | ||
| Iothalamate Sodium | C | ||
| Iothalaimic Acid | C | ||
| Iotrolan | C | ||
| Iotroxate Meglumine | C | ||
| Iotroxic Acid | C | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Ioxaglate Meglumine | C | ||
| Ioxaglate Sodium | C | ||
| Ioxaglic Acid | C | ||
| Ioxitalamate Meglumine | C | ||
| Ioxitalamate Sodium | C | ||
| Ioxitalamic Acid | C | ||
| Ipodate Calcium | C | ||
| Ipodate Sodium | C | ||
| Ipratropium Bromide | B | ||
| Iprindole Hydrochloride | A | ||
| Iproniazid Phosphate | A | ||
| Isoaminile | B | ||
| Isoaminile Citrate | B | ||
| Isocarboxazid | A | ||
| Isoconazole Nitrate | B | External (except vaginal use) | |
| Isoetharine | B | ||
| Isoetharine Hydrochloride | B | ||
| Isoetharine Mesylate | B | ||
| Isoniazid | B | ||
| Isoprenaline Hydrochloride | B | ||
| Isoprenaline Sulphate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Isopropamide Iodide | B | ||
| Isosorbide Dinitrate | B | ||
| Isosorbide Mononitrate | B | ||
| Isotretinoin | A | ||
| Isoxicam | B | ||
| Isoxsuprine Hydrochloride | B | ||
| Isradipine | B | ||
| Itraconazole | B | ||
| Jaborandi | B | External | |
| Kanamycin Sulphate | A | ||
| Ketamine Hydrochloride | A | ||
| Ketazolam | A | ||
| Ketoconazole | B | External (except vaginal use) | |
| Ketoprofen | B | 2.5 per cent (MS) 30.0g (MPS) | External: Rheumatic and muscular pain |
| Ketorolac | B | ||
| Ketorolac Trometamol | B | ||
| Ketotifen Fumarate | B | ||
| Labetolol Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Lamotrigine | B | ||
| Lanatoside C | B | ||
| Lanatoside Complex A, B and C | B | ||
| Latamoxef Disodium | A | ||
| Leuprorelin Acetate | A | ||
| Levallorphan Tartrate | B | ||
| Levamisole | A | ||
| Levamisole Hydrochloride | B | Anthelmintic | |
| Levobunolol Hydrochloride | B | ||
| Levodopa | B | ||
| Levorphanol Tartrate | A | ||
| Lidoflazine | A | ||
| Lignocaine | A | Any use except local ophthalmic use | |
| Lignocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Lincomycin | A | ||
| Lincomycin Hydrochloride | A | ||
| Liothyronine Sodium | B | ||
| Lisinopril | B | ||
| Lisuride Maleate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Lithium Carbonate | A | ||
| Lithium Succinate | B | ||
| Lithium Sulphate | A | ||
| Lobeline | B | (1) Internal | |
| (2) External | |||
| Lobeline Hydrochloride | B | (1) Internal | |
| (2) External | |||
| Lobeline Sulphate | B | (1) Internal | |
| (2) External | |||
| Lodoxamide | B | ||
| Lodoxamide Ethyl | B | ||
| Lodoxamide Tromethamine | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Lodoxamide Tromethamol | B | ||
| Lofepramine | A | ||
| Lofexidine Hydrochloride | B | ||
| Lomustine | A | ||
| Loperamide Hydrochloride | B | Treatment of acute diarrhoea | |
| Loprazolam Mesylate | A | ||
| Loratadine | B | 10mg (MS) 10 (MPS) | |
| Lorazepam | A | ||
| Lormetazepam | A | ||
| Loxapine | B | ||
| Loxapine Succinate | B | ||
| Luteinising Hormone | A | ||
| Lymecycline | A | ||
| Lynoestrenol | A | ||
| Lypressin | A | ||
| Lysuride Maleate | B | ||
| Mafenide | A | ||
| Mafenide Acetate | A | ||
| Mafenide Hydrochloride | A | ||
| Mafenide Propionate | A | 5.0 per cent (MS) | Eye drops |
| Magnesium Fluoride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Magnesium Metrizoate | B | ||
| Mandragora Autumnalis | B | ||
| Mannomustine Hydrochloride | A | ||
| Maprotiline Hydrochloride | B | ||
| Mazindol | A | ||
| Mebanazine | A | ||
| Mebendazole | B | Internal | |
| Mebeverine Hydrochloride | B | Internal | |
| Mebhydrolin | B | ||
| Mebhydrolin Napadisylate | B | ||
| Mecamylamine Hydrochloride | B | ||
| Mecillinam | A | ||
| Meclofenoxate Hydrochloride | B | ||
| Medazepam | A | ||
| Medicinal Opium | A | (1) Equivalent of 0.02 per cent of an-hydrous morphine (MS) | (1) Liquids |
| (2) Equivalent of 0.04 per cent of an-hydrous morphine (MS) | (2) Solids | ||
| Medigoxin | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Medrogestone | A | ||
| Medroxyprogesterone Acetate | A | ||
| Medrysone | A | ||
| Mefenamic Acid | B | ||
| Mefloquin Hydrochloride | B | Prophylaxis of malaria | |
| Mefruside | B | ||
| Megestrol | A | ||
| Megestrol Acetate | A | ||
| Meglumine Antimonate | A | ||
| Melperone | A | ||
| Melperone Hydrochloride | A | ||
| Melphalan | A | ||
| Melphalan Hydrochloride | A | ||
| Menotrophin | A | ||
| Mepenzolate Bromide | B | ||
| Mephenesin | B | ||
| Mephenesin Carbamate | B | ||
| Mepindolol | B | ||
| Mepivacaine Hydrochloride | A | Any use except local ophthalmic use | |
| Meprobamate | A | ||
| Meptazinol Hydrochloride | A | ||
| Mequitazine | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Mercaptopurine | A | ||
| Mercuric Chloride | B | ||
| Mercuric Iodide | B | ||
| Mersalyl | B | ||
| Mersalyl Acid | B | ||
| Mesalazine | B | ||
| Mesna | A | ||
| Mesterolone | A | ||
| Mestranol | A | ||
| Metaraminol Tartrate | B | ||
| Meteneprost | C | ||
| Metergoline | A | ||
| Metformin Hydrochloride | B | ||
| Methacycline | A | ||
| Methacycline Calcium | A | ||
| Methacycline Hydrochloride | A | ||
| Methadone Hydrochloride | A | ||
| Methallenoestril | A | ||
| Methandienone | A | ||
| Methapyrilene Fumarate | A | ||
| Methapyrilene Hydrochloride | A | ||
| Methaqualone | A | ||
| Methenolone Acetate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Methenolone Enanthate | A | ||
| Methicillin Sodium | A | ||
| Methiodal Sodium | C | ||
| Methixene | B | ||
| Methixene Hydrochloride | B | ||
| Methocarbamol | B | ||
| Methocidin | A | Throat lozenges and throat pastilles | |
| Methohexitone Sodium | A | ||
| Methoin | B | ||
| Methoserpidine | B | ||
| Methotrexate | A | ||
| Methotrexate Sodium | A | ||
| Methotrimeprazine | B | ||
| Methotrimeprazine Hydrochloride | B | ||
| Methotrimeprazine Maleate | B | ||
| Methoxamine Hydrochloride | B | 0.25 per cent (MS) | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle |
| Methsuximide | B | ||
| Methyclothiazide | B | ||
| Methylcysteine Hydrochloride | B | Internal | |
| Methylamphetamine Hydrochloride | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Methyldopa | B | ||
| Methyldopate Hydrochloride | B | ||
| Methylephedrine Hydrochloride | B | ||
| Methylphenidate Hydrochloride | A | ||
| Methylphenobarbitone | A | ||
| Methylprednisolone | A | ||
| Methylprednisolone Acetate | A | ||
| Methylprednisolone Sodium Succinate | A | ||
| Methyltestosterone | A | ||
| Methylthiouracil | B | ||
| Methyprylone | A | ||
| Methysergide Maleate | B | ||
| Metipranolol | B | ||
| Metirosine | A | ||
| Metoclopramide Hydrochloride | B | ||
| Metolazone | B | ||
| Metoprolol Fumarate | B | ||
| Metoprolol Succinate | B | ||
| Metoprolol Tartrate | B | ||
| Metrizoate Calcium | C | ||
| Metrizoate Sodium | C | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Metrizoic Acid | C | ||
| Metrizamide | C | ||
| Metronidazole | B | ||
| Metyrapone | B | ||
| Mexiletine Hydrochloride | B | ||
| Mezlocillin Sodium | A | ||
| Mianserin Hydrochloride | B | ||
| Miconazole | B | External (except vaginal use) | |
| Miconazole Nitrate | B | External (except vaginal use) | |
| Midazolam | A | ||
| Midodrine Hydrochloride | B | ||
| Mifepristone | C | ||
| Milrinone | B | ||
| Milrinone Lactate | B | ||
| Minocycline | A | ||
| Minocycline Hydrochloride | A | ||
| Minoxidil | B | ||
| Misoprostol | A | ||
| Mistletoe (Viscum album L) | A | ||
| Mithramycin | A | ||
| Mitobronitol | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Mitomycin C | A | ||
| Mitozantrone Hydrochloride | A | ||
| Mitrizoate | C | ||
| Meglumine | |||
| Moclobemide | A | ||
| Molindone Hydrochloride | B | ||
| Molsidocane | B | ||
| Molsidomine | B | ||
| Mopidamol | A | ||
| Morazone Hydrochloride | B | ||
| Morphine Hydrochloride | A | (1) Equivalent of 0.02 per cent of anhydrous morphine (MS) | (1) Liquids |
| (2) Equivalent of 0.04 per cent of anhydrous morphine; equivalent of 300 mcg of anhydrous morphine (MS) | (2) Solids | ||
| Morphine Sulphate | A | (1) Equivalent of 0.02 per cent of anhydrous morphine (MS) | (1) Liquids |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| (2) Equivalent of 0.04 per cent of anhydrous morphine; equivalent of 300mcg of anhydrous morphine (MS) | (2) Solids | ||
| Mupirocin | A | ||
| Mustine Hydrochloride | A | ||
| Nabilone | A | ||
| Nabumetone | B | ||
| Nadolol | B | ||
| Nafarelin Acetate | A | ||
| Naftidrofuryl Oxalate | B | ||
| Nalbuphine Hydrochloride | A | ||
| Nalidixic Acid | A | ||
| Nalorphine Hydrobromide | A | ||
| Nalorphine Hydrochloride | A | ||
| Naloxone Hydrochloride | A | ||
| Naltrexone Hydrochloride | A | ||
| Nandrolone Decanoate | A | ||
| Nandrolone Laureate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Nandrolone Phenylpropionate | A | ||
| Naphazoline Hydrochloride | B | (1) 0.05 per cent (MS) | (1) Nasal sprays or nasal drops not containing liquid paraffin as a vehicle |
| (2) 0.015 per cent (MS) | (2) Eye drops | ||
| Naphazoline Nitrate | B | (1) 0.05 per cent (MS) | (1) Nasal sprays or nasal drops not containing liquid paraffin as a vehicle |
| (2) 0.015 per cent (MS) | (2) Eye drops | ||
| Naproxen | B | 5.0 per cent (MS) 30.0g (MPS) | External: Rheumatic and muscular pain |
| Naproxen Sodium | B | ||
| Natamycin | A | ||
| Nedocromil Sodium | B | ||
| Nefopam Hydrochloride | B | ||
| Neomycin | A | ||
| Neomycin Oleate | A | ||
| Neomycin Palmitate | A | ||
| Neomycin Sulphate | A | ||
| Neomycin Undecanoate | A | ||
| Neostigmine Bromide | B | ||
| Neostigmine Methylsulphate | B | ||
| Netilmicin Sulphate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Nialamide | A | ||
| Nicardipine Hydrochloride | B | ||
| Niclosamide | B | ||
| Nicotine | B | Internal: Oral dosage forms | |
| Nicotine Resinate | B | Internal: Oral dosage forms | |
| Nicoumalone | B | ||
| Nifedipine | B | ||
| Nifenazone | B | ||
| Nikethamide | B | ||
| Nimetazepam | A | ||
| Nimodipine | B | ||
| Nimorazole | B | ||
| Niridazole | B | ||
| Nitrazepam | A | ||
| Nitrofurantoin | B | ||
| Nitrofurazone | B | ||
| Nizatidine | B | ||
| Nomifensine Maleate | A | ||
| Noradrenaline | B | ||
| Noradrenaline Acid Tartrate | B | ||
| Nordiazepam | A | ||
| Norethandrolone | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Norethisterone | A | ||
| Norethisterone Acetate | A | ||
| Norethisterone Heptanoate | A | ||
| Norethynodrel | A | ||
| Norfloxacin | A | ||
| Norgestimate | A | ||
| Norgestrel | A | ||
| Nortriptyline Hydrochloride | A | ||
| Noscapine | B | ||
| Noscapine Hydrochloride | B | ||
| Novobiocin Calcium | A | ||
| Novobiocin Sodium | A | ||
| Nux Vomica Seed | B | ||
| Nystatin | B | External (except vaginal use) | |
| Octacosactrin | A | ||
| Octreoide | A | ||
| Octreotide Acetate | A | ||
| Oestradiol | A | ||
| Oestradiol Benzoate | A | ||
| Oestradiol Cypionate | A | ||
| Oestradiol Dipropionate | A | ||
| Oestradiol Diundecanoate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Oestradiol Enanthate | A | ||
| Oestradiol Phenylpropionate | A | ||
| Oestradiol Undecanoate | A | ||
| Oestradiol Valerate | A | ||
| Oestriol | A | ||
| Oestriol Dihemisuccinate | A | ||
| Oestrogenic Substances Conjugated | A | ||
| Oestrone | A | ||
| Ofloxacin | A | ||
| Olsalazine Sodium | B | ||
| Omeprazole | B | ||
| Ondansetron Hydrochloride | A | ||
| Opipramol Hydrochloride | A | ||
| Orciprenaline Sulphate | B | ||
| Orphenadrine Citrate | B | ||
| Orphenadrine Hydrochloride | B | ||
| Ouabain | B | ||
| Ovarian Gland Dried | A | ||
| Oxamniquine | B | ||
| Oxandrolone | A | ||
| Oxantel Pamoate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Oxatomide | B | ||
| Oxazepam | A | ||
| Oxazolam | A | ||
| Oxedrine Tartrate | B | ||
| Oxiconazole Nitrate | B | ||
| Oxidronate Sodium | A | ||
| Oxitropium Bromide | B | ||
| Oxolinic Acid | B | ||
| Oxpentifylline | B | ||
| Oxprenolol Hydrochloride | B | ||
| Oxybuprocaine Hydrochloride | B | Any use except local ophthalmic use | |
| Oxybutynin Hydrochloride | B | ||
| Oxycodone Hydrochloride | A | ||
| Oxycodone Pectinate | A | ||
| Oxymetholone | A | ||
| Oxypertine | B | ||
| Oxypertine Hydrochloride | B | ||
| Oxyphenbutazone | B | ||
| Oxyphencyclimine Hydrochloride | B | ||
| Oxyphenonium Bromide | B | ||
| Oxytetracycline | A | ||
| Oxytetracycline Calcium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Oxytetracycline Dihydrate | A | ||
| Oxytetracycline Hydrochloride | A | ||
| Oxytocin, natural | B | ||
| Oxytocin, synthetic | B | ||
| Pamidronate Disodium | A | ||
| Pancuronium Bromide | A | ||
| Papaveretum | A | ||
| Papaverine | B | (1) By inhaler (2) Otherwise than by inhaler | |
| Papaverine Hydrochloride | B | (1) By inhaler | |
| (2) Otherwise than by inhaler | |||
| Paracetamol | B | ||
| Paraldehyde | B | ||
| Paramethadione | B | ||
| Paramethasone Acetate | A | ||
| Parathyroid Gland | A | ||
| Pargyline Hydrochloride | A | ||
| Paroxetine Hydrochloride | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Pecilocin | A | ||
| Pemoline | A | ||
| Pempidine Tartrate | B | ||
| Penamecillin | A | ||
| Penbutolol Sulphate | B | ||
| Penfluridol | A | ||
| Penicillamine | B | ||
| Penicillamine Hydrochloride | B | ||
| Pentaerythritol Tetranitrate | B | ||
| Pentagastrin | A | ||
| Pentamidine | A | ||
| Pentamidine Isethionate | A | ||
| Pentazocine Hydrochloride | A | ||
| Pentazocine Lactate | A | ||
| Penthienate Methobromide | B | ||
| Pentobarbitone | A | ||
| Pentobarbitone Sodium | A | ||
| Pentolinium Tartrate | B | ||
| Pentyl Nitrite | A | ||
| Pergolide Mesylate | B | ||
| Perhexiline Maleate | B | ||
| Pericyazine | B | ||
| Perindopril | B | ||
| Permethrin | B | External | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Perphenazine | B | ||
| Pethidine Hydrochloride | A | ||
| Phenacetin | A | 0.1 per cent (MS) | External |
| Phenazone | B | External | |
| Phenazone and Caffeine Citrate | B | ||
| Phenazone Salicylate | B | ||
| Phenbutrazate Hydrochloride | A | ||
| Phenelzine Sulphate | A | ||
| Phenethicillin Potassium | A | ||
| Phenformin Hydrochloride | B | ||
| Phenglutarimide Hydrochloride | B | ||
| Phenindione | B | ||
| Phenmetrazine Hydrochloride | A | ||
| Phenobarbitone | A | ||
| Phenobarbitone Sodium | A | ||
| Phenoperidine Hydrochloride | A | ||
| Phenothrin | B | External | |
| Phenoxybenzamine Hydrochloride | B | ||
| Phenoxymethylpenicillin | A | ||
| Phenoxymethylpenicillin Calcium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Phenoxymethylpenicillin Potassium | A | ||
| Phenprocoumon | B | ||
| Phensuximide | B | ||
| Phentermine Hydrochloride | A | ||
| Phentermine Resinate | A | ||
| Phentolamine Hydrochloride | B | ||
| Phentolamine Mesylate | B | ||
| Phenylbutazone | A | ||
| Phenylbutazone Sodium | A | ||
| Phenylephrine Bitartrate | B | Internal | |
| Phenylephrine Hydrochloride | B | (1) Internal (other than controlled release capsules and tablets, nasal sprays and nasal drops) | |
| (2) controlled release capsules and tablets | |||
| (3) 0.5 per cent (MS) | (3) nasal sprays and nasal drops | ||
| (4) External (except local ophthalmic use) | |||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Phenylmethyl-barbituric Acid | A | ||
| Phenylpropanolamiine Hydrochloride | B | Internal: (1) all preparations except controlled release capsules, nasal sprays and nasal drops | |
| (2) controlled release capsules | |||
| (3) 2.0 per cent | (3) nasal sprays and nasal drops | ||
| Phenylpropanolamine resinate | B | Internal | |
| Phenytoin | B | ||
| Phenytoin Sodium | B | ||
| Pholcodine | A | 1.5 per cent (MS) | |
| Pholcodine Citrate | A | Equivalent of 1.5 per cent of Pholcodine (MS) | |
| Pholcodine Tartrate | A | Equivalent of 1.5 per cent of Pholcodine (MS) | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Phthalylsulphathiazole | B | ||
| Physostigmine | B | ||
| Physostigmine Aminoxide Salicylate | B | ||
| Physostigmine Salicylate | B | ||
| Physostigmine Sulphate | B | ||
| Picrotoxin | B | ||
| Pilocarpine | B | ||
| Pilocarpine Hydrochloride | B | ||
| Pilocarpine Nitrate | B | ||
| Pimozide | B | ||
| Pinacidil | B | ||
| Pinazepam | A | ||
| Pindolol | B | ||
| Pipenzolate Bromide | B | ||
| Piperacillin Sodium | A | ||
| Piperazine Oestrone Sulphate | A | ||
| Piperidolate Hydrochloride | B | ||
| Pipothiazine Palmitate | B | ||
| Pipradrol Hydrochloride | A | ||
| Piracetam | B | ||
| Pirbuterol Acetate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Pirbuterol Hydrochloride | B | ||
| Pirenzepine Hydrochloride | A | ||
| Piretanide | B | ||
| Piritramide | A | ||
| Piromidic Acid | A | ||
| Piroxicam | B | 0.5 per cent (MS) 30.0g (MPS) | External: Rheumatic and muscular pain |
| Pirprofen | B | ||
| Pituitary Gland (Whole Dried) | B | ||
| Pituitary Powdered (Posterior Lobe) | B | ||
| Pivampicillin Hydrochloride | A | ||
| Pivmecillinam | A | ||
| Pivmecillinam Hydrochloride | A | ||
| Pizotifen | B | ||
| Pizotifen Maleate | B | ||
| Podophyllotoxin | B | ||
| Podophyllum | B | ||
| Podophyllum Indian | B | ||
| Podophyllum Resin | B | 20.0 per cent (MS) | External |
| Poke Root (Phytolacca Species) | A | ||
| Poldine Methylsulphate | B | ||
| Polidexide | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Polyestradiol Phosphate | A | ||
| Polymyxin B Sulphate | A | ||
| Polythiazide | B | ||
| Poppy Capsule | A | ||
| Potassium Arsenite | B | 0.0127 per cent (MS) | |
| Potassium Bromide | B | ||
| Potassium Perchlorate | B | ||
| Practolol | B | ||
| Pralidoxime Chloride | B | ||
| Pralidoxime Iodide | B | ||
| Pralidoxime Mesylate | B | ||
| Pravastatin | B | ||
| Pravastatin Sodium | B | ||
| Prazepam | A | ||
| Prazosin Hydrochloride | B | ||
| Prednisolone | A | ||
| Prednisolone 21-Steglate | A | ||
| Prednisolone Acetate | A | ||
| Prednisolone Butylacetate | A | ||
| Prednisolone Hexanoate | A | ||
| Prednisolone Sulphoebenzoate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Prednisolone Pivalate | A | ||
| Prednisolone Sodium m-Sulphobenzoate | A | ||
| Prednisolone Sodium Phosphate | A | ||
| Prednisone | A | ||
| Prednisone Acetate | A | ||
| Prenalterol Hydrochloride | B | ||
| Prenylamine Lactate | B | ||
| Prilocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Primidone | B | ||
| Probenecid | B | ||
| Probucol | B | ||
| Procainamide Hydrochloride | B | ||
| Procaine Hydrochloride | A | Any use except local ophthalmic use | |
| Procaine Penicillin | A | ||
| Procarbazine Hydrochloride | A | ||
| Procaterol Hyrdochloride | B | ||
| Prochlorperazine Edisylate | B | ||
| Prochlorperazine Maleate | B | ||
| Prochlorperazine Mesylate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Procyclidine Hydrochloride | B | ||
| Progesterone | A | ||
| Proguanil Hydrochloride | B | Prophylaxis of malaria | |
| Prolactin | A | ||
| Proligestone | A | ||
| Prolintane Hydrochloride | A | ||
| Promazine Embonate | B | ||
| Promazine Hydrochloride | B | ||
| Propafenone Hydrochloride | B | ||
| Propanidid | B | ||
| Propantheline Bromide | B | ||
| Propizepine | A | ||
| Propofol | A | ||
| Propranolol Hydrochloride | B | ||
| Propyliodone | C | ||
| Propylthiouracil | B | ||
| Proquazone | B | ||
| Proscillaridin | B | ||
| Protamine Sulphate | B | ||
| Prothionamide | B | ||
| Protirelin | B | ||
| Protriptyline Hydrochloride | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Proxymetacaine Hydrochloride | B | Any use except local ophthalmic use | |
| Pseudoephedrine Hydrochloride | B | Internal: (1) All preparations except controlled release capsules and tablets | |
| (2) Controlled release capsules and tablets | |||
| Pseudoephedrine Sulphate | B | Internal: (1) All preparations except controlled release capsules and tablets | |
| (2) Controlled release capsules and tablets | |||
| Pyrantel Embonate | B | ||
| Pyrantel Tartrate | B | ||
| Pyrazinamide | B | ||
| Pyridostigmine Bromide | B | ||
| Pyridoxine Hydrochloride | B | ||
| Pyrimethamine | B | ||
| Quazepam | A | ||
| Quinalbarbitone | A | ||
| Quinalbarbitone Sodium | A | ||
| Quinapril | B | ||
| Quinapril Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Quinestradol | A | ||
| Quinestrol | A | ||
| Quinethazone | B | ||
| Quinidine | B | ||
| Quinidine Bisulphate | B | ||
| Quinidine Phenylethylbarbiturate | A | ||
| Quinidine Polygalacturonate | B | ||
| Quinidine Sulphate | B | ||
| Quinine | B | ||
| Quinine and Urea Hydrochloride | B | ||
| Quinine Bisulphate | B | ||
| Quinine Dihydrochloride | B | ||
| Quinine Ethyl Carbonate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Quinine Glycerophosphate | B | ||
| Quinine Hydrobromide | B | ||
| Quinine Hydrochloride | B | ||
| Quinine Iodobismuthate | B | ||
| Quinine Phenyl-cinchoninate | B | ||
| Quinine Phosphate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Quinine Salicylate | B | ||
| Quinine Sulphate | B | ||
| Quinine Tannate | B | ||
| Radionuclide compounds | C | ||
| Radionuclides | C | ||
| Ragworth (Senecio jacobaea L) | A | ||
| Ramipril | B | ||
| Ranitidine Hydrochloride | B | ||
| Rauwolfia Serpentina | B | ||
| Rauwolfia Vomitoria | B | ||
| Razoxane | A | ||
| Remoxipride Hydrochloride | A | ||
| Reproterol Hydrochloride | B | ||
| Rescinnamine | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Reserpine | B | ||
| Rifampicin | A | ||
| Rifamycin | A | ||
| Rimiterol Hydrobromide | B | ||
| Ritodrine Hydrochloride | B | ||
| Rolitetracycline Nitrate | A | ||
| Rosoxacin | A | ||
| Sabadilla | B | ||
| Safrole | A | ||
| Salbutamol | B | ||
| Salbutamol Sulphate | B | ||
| Salcatonin | B | ||
| Salcatonin Hydrated Polyacetate | B | ||
| Salmefamol | B | ||
| Salmeterol | B | ||
| Salmeterol Xinafoate | B | ||
| Salsalate | B | ||
| Saralasin Acetate | B | ||
| Sassafras Bark | A | ||
| Sassafras Oil | A | ||
| Sassafras Root | A | ||
| Secbutobarbitone | A | ||
| Secbutobarbitone Sodium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Secretin | B | ||
| Selegiline Hydrochloride | B | ||
| Sera and Antisera:— | |||
| Botulin Antitoxin | A | ||
| Diphtheria Antitoxin | A | ||
| Gas-gangrene Antitoxin (Oedematiens) | A | ||
| Gas-gangrene Antitoxin (Perfringens) | A | ||
| Gas-gangrene Antitoxin (Septicum) | A | ||
| Leptospira Antiserum | A | ||
| Mixed Gas-gangrene Antitoxin | A | ||
| Rabies Antiserum | A | ||
| Scorpion Venom Antiserum | A | ||
| Serum Gonadetrophin | A | ||
| Snake Venom Antiserum | A | ||
| Tetanus Antitoxin | A | ||
| Sermorelin | A | ||
| Sermorelin Acetate | A | ||
| Sertraline Hydrochloride | A | ||
| Simvastatin | B | ||
| Sissomicin | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Sissomicin Sulphate | A | ||
| Snake Venoms | B | ||
| Sodium Aminosalicylate | B | ||
| Sodium Antimonylgluconate | B | ||
| Sodium Arsanilate | B | ||
| Sodium Arsenate | B | ||
| Sodium Arsenite | B | 0.013 per cent (MS) | |
| Sodium Bromide | B | ||
| Sodium Fluoride | B | (1) 0.33 per cent (MS) | (1) Dentifrices |
| (2) Other preparations for use in the prevention of dental caries in the form of:— | |||
| (a) tablets or drops | |||
| (b) 0.2 per cent (MS) | (b) mouth rinses other than those for daily use | ||
| (c) 0.05 per cent (MS) | (c) mouth rinses for daily use | ||
| Sodium Fusidate | A | ||
| Sodium Metrizoate | B | ||
| Sodium Monofluorophosphate | B | 1.14 per cent (MS) | Dentifrice |
| Sodium Stibogluconate | B | ||
| Somatorelin | A | ||
| Somatotrophin | A | ||
| Somatrem | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Somatropin | A | ||
| Sotalol Hydrochloride | B | ||
| Spectinomycin | A | ||
| Spectinomycin Hydrochloride | A | ||
| Spiramycin | A | ||
| Spiramycin Adipate | A | ||
| Spironolactone | A | ||
| Stannous Flouride | B | 0.62 per cent (MS) | Dentifrice |
| Stanolonetanozoid | A | ||
| Stenbolone Acetate | A | ||
| Stilboestrol | A | ||
| Stilboestrol Dipropionate | A | ||
| Streptodornase | B | External | |
| Streptokinase | B | External | |
| Streptomycin | A | ||
| Streptomycin Sulphate | A | ||
| Strophanthin-K | B | ||
| Strychnine | B | ||
| Strychnine Arsenate | B | ||
| Strychnine Hydrochloride | B | ||
| Styramate | B | ||
| Succinyl-sulphathiazole | B | ||
| Sufentanil Citrate | A | ||
| Sulbactam Sodium | A | ||
| Sulbactam Tosylate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Sulbenicillin | A | ||
| Sulbenicillin Sodium | A | ||
| Sulconazole Nitrate | B | External (except vaginal use) | |
| Sulfacytine | A | ||
| Sulfadoxine | A | ||
| Sulfametopyrazine | A | ||
| Sulfamono-methoxine | A | ||
| Sulindac | B | ||
| Suloctidil | B | ||
| Sulphacetamide | A | ||
| Sulphacetamide Sodium | A | ||
| Sulphadiazine | A | ||
| Sulphadiazine Silver | A | ||
| Sulphadiazine Sodium | A | ||
| Sulphadimidine | A | ||
| Sulphadimidine Sodium | A | ||
| Sulphafurazole | A | ||
| Sulphafurazole Diethanolamine | A | ||
| Sulphaguanidine | B | ||
| Sulphaloxate Calcium | A | ||
| Sulphaloxic Acid | B | ||
| Sulphamerazine | A | ||
| Sulphamerazine Sodium | A | ||
| Sulphamethizole | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Sulphamethoxazole | A | ||
| Sulphamethoxydiazine | A | ||
| Sulphamethoxypyridazine | A | ||
| Sulphamethoxypyridazine Sodium | A | ||
| Sulphamoxole | A | ||
| Sulphaphenazole | A | ||
| Sulphanilamide | A | ||
| Sulphanilamide, N-Benzoyl | A | ||
| Sulphapyridine | A | ||
| Sulphapyridine Sodium | A | ||
| Sulphasalazine | B | ||
| Sulphathiazole | A | ||
| Sulphathiazole Sodium | A | ||
| Sulphaurea | A | ||
| Sulphinpyrazone | B | ||
| Sulpiride | B | ||
| Sulprostone | C | ||
| Sultamicillin | A | ||
| Sultamicillin Tosylate | A | ||
| Sulthiame | B | ||
| Sumatriptan | B | ||
| Sumatriptan Hemisuccinate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Sumatriptan Succinate | B | ||
| Sutoprofen | B | ||
| Suxamethonium Bromide | A | ||
| Suxamethonium Chloride | A | ||
| Suxethonium Bromide | A | ||
| Tacrine Hydrochloride | A | ||
| Talampicillin | A | ||
| Talampicillin Hydrochloride | A | ||
| Talampicillin Napsylateamoxifen | A | ||
| Tamoxifen Citrate | A | ||
| Taurolidine | B | ||
| Teicoplanin | A | ||
| Temafloxacin | A | ||
| Temafloxacin Hydrochloride | A | ||
| Temazepam | A | ||
| Temocillin | A | ||
| Temocillin Sodium | A | ||
| Teniposide | A | ||
| Tenoxicam | B | ||
| Terazosin Hydrochloride | B | ||
| Terbutaline | B | ||
| Terbutaline Sulphate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Terfenadine | B | 120mg (MS) 10 (MPS) | |
| Terlipressin | A | ||
| Terodiline Hydrochloride | B | ||
| Tertatolol Hydrochloride | B | ||
| Testosterone | A | ||
| Testosterone 17ß Chloral Hemiacetal | A | ||
| Testosterone Acetate | A | ||
| Testosterone Cyclohexylpropionate | A | ||
| Testosterone Cypionate | A | ||
| Testosterone Decanoate | A | ||
| Testosterone Enanthate | A | ||
| Testosterone Isocaproate | A | ||
| Testosterone Phenylpropionate | A | ||
| Testosterone Propionate | A | ||
| Testosterone Undecanoate | A | ||
| Tetrabenazine | B | ||
| Tetracosactrin | A | ||
| Tetracosactrin Acetate | A | ||
| Tetracycline | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Tetracycline Hydrochloride | A | ||
| Tetracycline Phosphate Complex | A | ||
| Tetrazepam | A | ||
| Thallium Acetate | A | ||
| Thallous Chloride | A | ||
| Theophylline | B | ||
| Thiambutosine | B | ||
| Thiamphenicol | A | ||
| Thiamphenicol Glycinate Hydrochloride | A | ||
| Thiamphenicol Palmitate | A | ||
| Thiethylperazine | B | ||
| Thiethylperazine Malate | B | ||
| Thiethylperazine Maleate | B | ||
| Thiocarlide | B | ||
| Thioguanine | A | ||
| Thiopentone Sodium | A | ||
| Thiopropazate Hydrochloride | B | ||
| Thioproperazine Mesylate | B | ||
| Thioridazine | B | ||
| Thioridazine Hydrochloride | B | ||
| Thiosinamine | A | ||
| Thiotepa | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Thiothixene | B | ||
| Thiouracil | B | ||
| Thymoxamine Hydrochloride | B | ||
| Thyroid | B | ||
| Thyrotrophin | A | ||
| Thyroxine Sodium | B | ||
| Tiamulin Fumarate | A | ||
| Tiaprofenic Acid | B | ||
| Tibezonium Iodide | A | ||
| Tibolone | A | ||
| Ticarcillin Sodium | A | ||
| Tienilic Acid | B | ||
| Tigloidine Hydrobromide | B | ||
| Timolol Maleate | B | ||
| Tinidazole | B | ||
| Tinzaparin Sodium | A | ||
| Tioconazole | B | External (except vaginal use) | |
| Tizanidine Hydrochloride | A | ||
| Tobramycin Sulphate | A | ||
| Tocainide Hydrochloride | B | ||
| Tofenacin Hydrochioride | B | ||
| Tofisopam | A | ||
| Tolazamide | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substances | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Tolazoline Hydrochloride | B | External | |
| Tolbutamide | B | ||
| Tolbutamide Sodium | B | ||
| Tolmetin Sodium | B | ||
| Tolobuterol Hydrochloride | B | ||
| Tolrestat | B | ||
| Tramazoline Hydrochloride | B | ||
| Tranexamic Acid | B | ||
| Tranylcypromine Sulphate | A | ||
| Trazodone Hydrochloride | B | ||
| Trenbolone Acetate | A | ||
| Treosulfan | A | ||
| Tretinoin | B | ||
| Triamcinolone | A | ||
| Triamcinolone Acetonide | A | ||
| Triamcinolone Diacetate | A | ||
| Triamcinolone Hexacetonide | A | ||
| Triamterene | B | ||
| Triazolam | A | ||
| Tribavirin | A | ||
| Triclofos Sodium | B | ||
| Trientine Hydrochloride | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Trifluoperazine | B | ||
| Trifluoperazine Hydrochloride | B | ||
| Trifluperidol | A | ||
| Trifluperidol Hydrochloride | A | ||
| Trilostane | A | ||
| Trimazosin Hydrochloride | B | ||
| Trimeprazine | B | ||
| Trimeprazine Tartrate | B | ||
| Trimetaphan Camsylate | B | ||
| Trimetazidine | B | ||
| Trimetazidine Hydrochloride | B | ||
| Trimethoprim | A | ||
| Trimipramine Maleate | A | ||
| Trimipramine Mesylate | A | ||
| Triptorelin | A | ||
| Tropicamide | B | ||
| Tropicamide | A | ||
| Troxidone | B | ||
| L-Tryptophan | B | External | |
| Tubocurarine Chloride | A | ||
| Tulobuterol Hydrochloride | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Tyropanoate Sodium | C | ||
| Tyrothricin | A | Throat lozenges and throat pastilles | |
| Uramustine | A | ||
| Urapidil | B | ||
| Urea Stibamine | B | ||
| Urethane | A | ||
| Uridine-5-Triphosphoric Acid | B | ||
| Urofollitrophin | A | ||
| Urokinase | B | ||
| Ursodeoxycholic Acid | B | ||
| Vaccines:— | |||
| Anthrax Vaccine (Bacillus Anthracis) | A | ||
| Bacillus Calmette-Guerin Vaccine | A | ||
| Bacillus Calmette-Guerin Vaccine (Percutaneous) | A | ||
| Cholera Vaccine | A | ||
| Diphtheria and Tetanus Vaccine | A | ||
| Diphtheria and Tetanus Vaccine (Adsorbed) | A | ||
| Diphtheria, Tetanus and Pertussis Vaccine | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substances | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) | A | ||
| Diphtheria, Tetanus and Poliomyelitis Vaccine | A | ||
| Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine | A | ||
| Diphtheria Vaccine | A | ||
| Diphtheria Vaccine (Adsorbed) | A | ||
| Eltor Vaccine | A | ||
| Haemophilus Influenza Vaccine | A | ||
| Haemophilus Type B Polysaccharide Conjugate Vaccine | A | ||
| Hepatitis A Vaccine | A | ||
| Hepatitis B Vaccine | A | ||
| Hepatitis B Virus Vaccine (Inactivated) | A | ||
| Influenza Vaccine | A | ||
| Measles, Mumps and Rubella Virus Vaccine (Live) | A | ||
| Measles Vaccine (Live Attenuated) | A | ||
| Old Tuberculin | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Pertussis Vaccine | A | ||
| Plague Vaccine | A | ||
| Pneumococcal Vaccine (Bacterial Antigen) | A | ||
| Poliomyelitis Vaccine (Inactivated) | A | ||
| Poliomyelitis Vaccine (Oral) | A | ||
| Rabies Vaccine | A | ||
| Rubella Vaccine (Live Attenuated) | A | ||
| Schick Control | A | ||
| Schick Test Toxin | A | ||
| Smallpox Vaccine | A | ||
| Smallpox Vaccine (Dried) | A | ||
| Tetanus Vaccine | A | ||
| Tetanus Vaccine (Adsorbed) | A | ||
| Tuberculin Purified Protein Derivative | A | ||
| Typhoid and Tetanus Vaccine | A | ||
| Typhoid-paratyphoid A and B and Cholera Vaccine | A | ||
| Typhoid-paratyphoid A and B and Tetanus Vaccine | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Thphoid-paratyphoid A and B Vaccine | A | ||
| Typhoid Vaccine | A | ||
| Typhus Vaccine | A | ||
| Yellow Fever Vaccine | A | ||
| Valproate Sodium | B | ||
| Valproic Acid | B | ||
| Vancomycin Hydrochloride | A | ||
| Vasopressin | A | ||
| Vasopressin Tannate | A | ||
| Vecuronium Bromide | A | ||
| Veralipride | B | ||
| Verapamil Hydrochloride | B | ||
| Veratrine | B | ||
| Veratrum (Green and White) | B | ||
| Vidarabine | A | ||
| Vigabatrin | B | ||
| Viloxazine Hydrochloride | B | ||
| Vinblastine Sulphate | A | ||
| Vincristine Sulphate | A | ||
| Vindesine Sulphate | A | ||
| Viomycin Pantothenate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Viomycin Sulphate | A | ||
| Vitamin A | B | (1) Internal | |
| (2) External | |||
| Vitamin A Acetate | B | (1) Internal | |
| (2) External | |||
| Vitamin A Palmitate | B | (1) Internal | |
| (2) External | |||
| Warfarin | B | ||
| Warfarin Sodium | B | ||
| Xamoterol Fumarate | B | ||
| Xipamide | B | ||
| Yohimbine Hydrochloride | B | ||
| Zeranol | A | ||
| Zidovudine | A | ||
| Zimeldine Hydrochloride | A | ||
| Zomepirac Sodium | B | ||
| Zopiclone | A | ||
| Zuclopenthixol | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength and Maximum Pack Size | Use, pharmaceutical form or manner of administration |
| Zuclopenthixol Acetate | A | ||
| Zuclopenthixol Decanoate | A | ||
| Zuclopenthixol Hydrochloride | A |
This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.
This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence.
Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.